All SEC Filings :: CV Sciences, Inc. (CVSI)

Investors

Investors

CV Sciences operates two distinct divisions: pharmaceuticals and consumer products. These divisions are supported by our medical and scientific advisory board, and state‐of‐the art production facilities.

All SEC Filings

Filing Type:

Year:

Date	Form	Description	PDF	XBRL	Pages
11/14/13	10-Q	Quarterly report pursuant to Section 13 or 15(d) Documents EX-10.2 EX-31.1 EX-32.1 EX-99.1			37
11/13/13	8-K	Current report filing			2
11/05/13	8-K	Current report filing			2
08/14/13	8-K	Current report filing			2
08/13/13	10-Q	Quarterly report pursuant to Section 13 or 15(d) Documents EX-2.1 EX-3.1 EX-3.2 EX-31.1 EX-32.1 EX-99.1			48
07/31/13	8-K	Current report filing Documents EX-4.1 EX-10.1			24
06/24/13	DEF 14A	Definitive proxy statements			65
06/21/13	8-K	Current report filing Documents EX-99.1			4
06/04/13	PRE 14A	Preliminary proxy statement not related to a contested matter or merger/acquisition			65
05/30/13	10-Q/A	Quarterly report pursuant to Section 13 or 15(d) Documents EX-31.1 EX-32.1			22

30
31
32
33
34
35
36
37
38
39